MARY GARDNER: Open Payments
NPI 1033791843 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,756 in 103 payments from 20 companies in 2025. Trend: 2023 $1,910 · 2024 $1,699 · 2025 $1,756
Food & beverage: $1,756
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 23 | $298 |
| PFIZER INC. | 8 | $182 |
| Merck Sharp & Dohme LLC | 9 | $176 |
| Amgen Inc. | 10 | $174 |
| Novartis Pharmaceuticals Corporation | 10 | $172 |
| Alnylam Pharmaceuticals Inc. | 15 | $161 |
| Novo Nordisk Inc | 5 | $134 |
| Boston Scientific Corporation | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Baxter Healthcare | 3 | $54 |
Products named: CAMZYOS, VYNDAQEL, REPATHA, LEQVIO, ONPATTRO, VERQUVO, ELIQUIS, Wegovy.
Industry payments across CA — which companies pay providers there.
